Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Post by maysteeler23on Jan 30, 2021 9:42pm
830 Views
Post# 32430057

GME is a joke. MMED is a revolution. Let’s squeeze

GME is a joke. MMED is a revolution. Let’s squeezeGME will be gone in 5 years,  but if we short squeeze MMED,  we will bring attention to a new consciousness that will transform the world.

Get into mindmedinvestors club  on Reddit and let's take this play to $30 in one day and make the revolution about something.

Fundamentally it's easier to squeeze a Canadian stock.  Americans can buy MMEDF.

Who knows, with the right kind of funding MMED might make the dark corridors of the mind bright and who knows - might even cure cancer.

Make sure to talk in code.  Don't give anything away.  Get everyone you know to invest what they can afford to lose and let's set a date when we will flood the shorts - remember talk in code.  Let's take this revolution to a new consciousness and let's make a lasting Mark for humanity, not just a money brag.

cheers
<< Previous
Bullboard Posts
Next >>